We are a clinical-stage biotechnology company revolutionizing the discovery and development process for novel peptide therapeutics for patients with serious and life-threatening diseases. Combining the untapped potential of peptide biology with the power of machine learning, we strive to scale our drug design approach and usher in the next generation of peptide therapeutics through precision engineering and design. Our lead peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective currently being investigated in clinical studies as a potential treatment for prosthetic joint infection, a historically difficult-to-treat ...
See more
Loading...
Resources
On the Blog
This information was provided by Mployer and is based on publicly available information made available by employers, brokers and carriers. While efforts are made to validate and confirm the information, there could be inaccuracies. All information and ratings are based on Mployer’s opinion only and should be one of many factors used when evaluating brokers. If there are any inaccuracies in the information, please reach out to Mployer using the contact us form and we will review your submission and make changes as we deem appropriate.